Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a clinical-stage biotechnology company dedicated to creating small molecule drugs for virology and immunol ...

A single modification in the protein found on the surface of the highly pathogenic avian influenza (HPAI) H5N1 influenza virus currently circulating in U.S. dairy cows could allow for easier ...

The 3-part order also requires affected farms to share epidemiologic information and any positive test results.

In its latest variant proportion estimates today, the CDC said levels of the XEC variant, now at 44%, continue to rise and ...

Despite a relatively slow start to respiratory disease season, low vaccination rates threaten that trend and the rapid rise of some illnesses is already putting children at increased risk.

New York City data highlight the benefits of early administration of nirsevimab to safeguard infants from respiratory ...

Fact checked by Nick Blackmer Experts have warned of the “triple threat”—influenza, COVID-19, and respiratory syncytial virus ...

Townsquare Capital LLC boosted its holdings in Moderna, Inc. (NASDAQ:MRNA – Free Report) by 42.7% during the 3rd quarter, ...

Adults aged 60 to 75 years old, pregnant women, and children under 2 are at the highest risk of respiratory illnesses this ...

Respiratory illness season has begun, and state and local health officials encourage everyone to protect themselves and their ...

For many of us, hopefully most of us, this is a time of vaccination. There’s the annual flu shot, of course, but also the ...

Vaccination rates for the flu, Covid-19 and respiratory syncytial virus (RSV) are low for adults in the U.S. so far this season, according to a new report from the Centers for Disease Control and ...